Related Experiment Video
Updated: May 11, 2026

Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol
Published on: July 28, 2018
The adjunctive effect of nebulized furosemide in COPD exacerbation: a randomized controlled clinical trial
Hojat Sheikh Motahar Vahedi1, Babak Mahshidfar, Helaleh Rabiee
1Emergency Department, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Objective:
To examine the effect of nebulized furosemide as an adjunct to the conventional treatment of patients with COPD exacerbation in an emergency department.
Methods:
In this randomized double-blinded clinical trial, patients with COPD exacerbation were randomized to receive 40 mg nebulized furosemide or placebo as an adjunct to the conventional treatments. We recorded changes in dyspnea severity (measured with a visual analog scale), FEV1, arterial blood gas measurements, blood pressure, heart rate, and breathing frequency at baseline and 1 hour after treatment.
Results:
We randomized 100 patients, whose mean age was 73.1 ± 8.7 y. The measured variables all improved significantly in both groups. FEV1, dyspnea, pH, mean blood pressure, and heart rate improved significantly more in the furosemide group.
Conclusions:
Nebulized furosemide benefits patients with COPD exacerbation.
Related Concept Videos
COPD: Management Using Bronchodilators and Corticosteroids
Heart Failure V: Medical Management
Heart Failure VI: Adjunct Therapies
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Heart Failure Drugs: Diuretics